A venous access port assembly having a housing base with a discharge port, a septum, and a cap, with an interior reservoir. The housing base is provided with X-ray discernable indicia to identify an attribute of the assembly after its implantation and clearly appear on an X-ray of the patient in a manner informing the radiologist or technologist and the medical practitioner of that particular attribute. Such indicia can be depicted as cutouts through a disc of radiopaque material where the cutouts are in the form of alphabetical letters such as CT, or can be a set of discrete elements of radiopaque material, that are affixed along the bottom surface of the housing base or embedded within the thickness of the bottom housing wall.

A tool is attachable to a bladder irrigation catheter. A body supports multiple fluid pathways between each of the catheter, a supply of irrigation fluid and a waste fluid collector. A syringe or other pressure and vacuum applicator accesses the pathways and powers irrigation flow. A supply port and intake port are connected to a supply pathway leading to the applicator. Similarly, a drain port and discharge port are connected to a drain pathway leading to the applicator. The supply pathway and drain pathway can be selectively blocked so that action of the applicator only drives supply or drain irrigation action. Check valves are located to provide proper fluid flow direction. Bypasses between the supply port and intake port and between the drain port and discharge port can be activated to bypass the supply pathway and drain pathway and allow for gravity flow bladder irrigation through the tool.

A pipe for fluid supply includes: a pipe configured integrally with an air feeding conduit and a pressure measurement conduit; inlets of the air feeding conduit and the pressure measurement conduit; outlets of the air feeding conduit and the pressure measurement conduit; and tube connection portions provided at the respective inlets in the pipe such that an angle between a vertical direction of the respective inlets and a vertical direction of each the respective outlets is 30 to 60.

Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

A probe device serves for insertion into a body of a patient. The probe device has a suction conduit between a distal suction feed port and a proximal suction attachment port for the attachment of a vacuum source. Moreover, the probe device has a feed conduit between a proximal feed attachment port, for the attachment of a feed source, and the distal suction feed port. This results in a probe device and a tube/connector assembly, which can be a component thereof, of which the versatility is improved in particular in the area of a medical application or an application in which biocompatibility is important.

A cable holder prevents fraying or tangling of cables configured to physically and electrically connect to one or more devices, such as patient monitoring devices. The cable holder can be configured to: (i) detachably secure the one or more cables, and (ii) be detachably secured to a support structure. The cable holder may include a first surface in which an aperture configured to receive a cable is defined, and a second surface on which a connector configured to removably interconnect with a connector of another cable holder is defined.

A method of treating a patient using a power-injectable access port, including implanting the power-injectable access port in the patient, imaging the power-injectable access port following implanting, and power injecting a fluid into the patient through the power-injectable access port. The power-injectable access port includes a septum covering a reservoir, the septum including a radiopaque material forming at least one letter, the at least one letter indicating that the power-injectable access port is suitable for power injection. The power-injectable access port is designed to accommodate a pressure developed within the reservoir of at least 35 psi, and a fluid flow rate of at least 1 milliliter per second. Imaging the power-injectable access port produces an image, and the method includes identifying the at least one letter on the image to confirm that the power-injectable access port is suitable for power injecting a fluid.

Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

A delivery adapter which may be used as an interface between a syringe and a catheter hub is described.

A method of using a power-injectable port includes obtaining the power-injectable access port, attaching a catheter to an outlet stem of the power-injectable access port, and implanting the power-injectable access port and the catheter into a patient. The method further includes identifying the power-injectable access port following the implanting, and in accordance with the identification, inserting a distal end of a needle through the septum and into the reservoir, and injecting contrast media through the needle at a rate of at least one milliliter per second. The power-injectable access port includes a housing, a septum, a reservoir, and an outlet stem in fluid communication with the reservoir. The power-injectable access port is rated for injection of contrast media at a flow rate of at least 1 milliliter per second. The power-injectable access port is structured for operation at a pressure in the reservoir of at least 35 psi.